Flavia Baccini
Overview
Explore the profile of Flavia Baccini including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
17
Citations
117
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ballesio A, Vacca M, Fiori V, Micheli F, Baccini F, Di Nardo G, et al.
J Sleep Res
. 2024 Nov;
:e14395.
PMID: 39506489
Insomnia has been suggested as a potential modulator of systemic inflammation. However, few studies have examined the longitudinal association between insomnia and inflammation as well as the role of sex...
2.
Ballesio A, Santamaria T, Furio S, Parisi P, Polese D, Micheli F, et al.
Physiol Behav
. 2024 Mar;
278:114510.
PMID: 38479583
Innate immunity may influence the onset of affective symptoms and alter sleep patterns in chronic inflammatory conditions. Here, we tested the prospective associations between baseline serum C-reactive protein (CRP), albumin,...
3.
Ballesio A, Micheli F, Baccini F, Zagaria A, Del Forno A, Fiori V, et al.
J Psychosom Res
. 2024 Jan;
177:111592.
PMID: 38217896
Objective: Inflammatory bowel disease (IBD) is often comorbid with mood disorders and depressive symptoms. The aetiology of depressive symptoms in IBD, however, remains largely unknown. Consistent with the inflammatory hypothesis...
4.
Ribaldone D, Parisio L, Variola A, Bossa F, Castiglione F, Marzo M, et al.
Dig Liver Dis
. 2023 Jul;
56(1):77-82.
PMID: 37474412
Background: The administration of biological drugs in inflammatory bowel diseases (IBD) is increasingly moving from intravenous to subcutaneous formulations. Aims: To evaluate the efficacy and safety of vedolizumab subcutaneous administration...
5.
Di Nardo G, Micheli F, Cozzi D, Mercantini P, Parisi P, Baccini F, et al.
J Pediatr Gastroenterol Nutr
. 2023 Feb;
76(5):646-651.
PMID: 36763990
Objectives: Standard capsule endoscopy (CE) is ineffective for upper gastrointestinal (GI) tract examination because it does not allow operator-controlled navigation of the capsule. Magnetically assisted capsule endoscopy (MACE) may offer...
6.
Ballesio A, Zagaria A, Baccini F, Micheli F, Di Nardo G, Lombardo C
Sleep Med Rev
. 2021 Jul;
60:101518.
PMID: 34214847
Evidence of poor sleep quality in inflammatory bowel disease (IBD, i.e., Crohn's disease and ulcerative colitis) has been reported but never systematically reviewed or meta-analysed. We conducted a systematic review...
7.
Di Nardo G, Esposito G, Ziparo C, Micheli F, Masoni L, Villa M, et al.
World J Gastroenterol
. 2020 Nov;
26(39):5944-5958.
PMID: 33132646
Inflammatory bowel disease (IBD) includes Crohn's disease (CD), ulcerative colitis and unclassified entities. CD commonly involves the terminal ileum and colon but at the time of diagnosis it can be...
8.
Saibeni S, Scucchi L, Dragoni G, Bezzio C, Miranda A, Ribaldone D, et al.
United European Gastroenterol J
. 2020 Oct;
8(10):1228-1235.
PMID: 33070758
Background And Aims: Restructuring activities have been necessary during the lockdown phase of the coronavirus disease 2019 (COVID-19) pandemic. Few data are available on the post-lockdown phase in terms of...
9.
Fantini M, Biancone L, Dragoni G, Bezzio C, Miranda A, Ribaldone D, et al.
Inflamm Bowel Dis
. 2020 Oct;
26(11):e134-e136.
PMID: 33029612
No abstract available.
10.
Festa S, Garbuglia A, Baccini F, Panzuto F, Capobianchi M, Santino I, et al.
Scand J Infect Dis
. 2014 Aug;
46(10):727-31.
PMID: 25134653
Hepatitis E virus (HEV) is the most important causative agent of acute hepatitis in developing countries. The disease is usually characterized by a self-limiting, benign course. However, when particular conditions...